All services

Lima 2016 FAST-ED (Field Assessment Stroke Triage for Emergency Destination): facial_palsy 0-1 + arm_weakness 0-2 + speech 0-2 + eye_deviation 0-2 + neglect 0-2. Max 9. lvo_suggested iff score ≥4. Bands 0_to_1 / 2_to_3 / gte_4. Time is documented for decision making (0 points, not scored). Not a stroke diagnosis or transfer order. magent does not examine the patient.

Schroeder 1987 ulcerative colitis disease-activity index (Mayo DAI): four caller-assigned integers 0-3 (stool frequency, rectal bleeding, endoscopy, physician global). magent sums only (max 12) and does not return later remission or activity-band cutoffs. magent does not count stools, examine the patient, or perform endoscopy. Not a diagnosis and not the Mayo SPN pulmonary-nodule model.

Rockwood 2005 CSHA Clinical Frailty Scale 1-7 as assigned by the caller (Box 1). Returns cfs, score, max 7, and the published label. Does not implement the later 9-point CFS (8 very severely frail, 9 terminally ill) or CFS 2.0 label changes. Not a diagnosis; magent does not examine the patient.

Caprini 2005 thrombosis risk assessment (Table 3): exclusive age (41-60=1, 61-74=2, >=75=3) and exclusive surgery (minor=1; arthroscopic/major/laparoscopic=2; arthroplasty=5) plus caller-assigned 1-, 2-, 3-, and 5-point flags. Max 78. Bands: 0-1 low, 2 moderate, 3-4 high, >=5 highest. Not a diagnosis. Not Caprini 2009/2013. Not a prophylaxis order.

Davis 2017 HEAVEN criteria from six caller-assigned flags: hypoxemia (SpO2 ≤93% at initial laryngoscopy as assigned), extremes of size (pediatric ≤8 years or clinical obesity as assigned), anatomic challenges, vomit/blood/fluid, exsanguination, and limited neck mobility. high_risk iff any is true; criteria_met is the count of true flags (0-6); low_risk iff none. Not an intubation order. magent does not measure SpO2 or examine the airway. Not Mallampati, not EGRI.

Condoluci 2020 IPS-E for asymptomatic early-stage chronic lymphocytic leukemia: unmutated IGHV 1, ALC >15 ×10^9/L 1, palpable lymph nodes 1; max 3. Low 0, intermediate 1, high 2–3. Time-to-first-treatment score, not a treatment start order; not CLL-IPI, Rai, or Binet. magent does not assay IGHV, count lymphocytes, or palpate nodes.

WHO 2016 polycythemia vera criteria (Arber 2016). Met when all three majors hold, or when major 1 and major 2 hold with subnormal EPO. Major 1 is male Hb >16.5 g/dL or Hct >49%, female Hb >16.0 or Hct >48%, or increased red-cell mass. Major 2 is caller-assigned marrow panmyelosis. Major 3 is JAK2 V617F or exon 12. Not a medical device, not a WHO diagnosis, and not WHO 2022. magent does not assay EPO or sequence JAK2.

Taylor 2006 CASPAR classification criteria for psoriatic arthritis. Required: inflammatory_articular_disease true (joint, spine, or enthesis). Score: current psoriasis 2; personal history 1 only if current is false; family history 1 only if current and personal are false; nail dystrophy 1; RF-negative 1; dactylitis (current or history) 1; juxtaarticular new bone 1. Classified iff score ≥3 (max 8). Not a diagnosis. Not Moll and Wright. magent does not examine skin or read films.

Aggarwal 2023 DOAC Score (Circulation Table 2) for AF on DOACs: age 65-69 2 / 70-74 3 / 75-79 4 / >=80 5 (<65 0); CrCl/eGFR 30-60 inclusive 1, <30 2; underweight caller BMI <18.5 flag 1; stroke/TIA/embolism 1; diabetes 1; hypertension 1; antiplatelet none 0, aspirin 2, dual 3; NSAID 1; bleeding history 3; liver disease 2. Score min(raw, 10). Bands 0-3 very_low, 4-5 low, 6-7 moderate, 8-9 high, 10 very_high. Not HAS-BLED. Not DOAC dosing. Not warfarin.

Chopra 2017 Michigan Risk Score for PICC-associated thrombosis: another CVC at PICC placement 1, WBC >12 x10^9/L 1 (12.0 does not score), active cancer 2, PICC lumens single 0 / double 2 / triple 3 (triple includes quad), VTE history never 0 / remote 2 / within 30 days 3 (one field; do not add remote and recent). Max 10. Classes I=0 (observed 0.9%), II=1-2 (1.6%), III=3-4 (2.7%), IV=>4 (4.7% Table 4). Not a PICC order. magent does not count lumens.

Longstreth 2006 Rome III IBS. rome_iii_ibs is true iff pain or discomfort at least 3 days per month in the last 3 months, onset at least 6 months prior, and at least two of: improvement with defecation, change in stool frequency, and change in stool form. supporting_features_met is 0-3. Caller assigns five flags. magent does not examine the patient. Not a diagnosis, not Rome IV, not IBS subtype.

Clive 2014 LENT score for malignant pleural effusion: pleural LDH IU/L (<1500 → 0, >1500 → 1), ECOG 0-4 (0→0, 1→1, 2→2, 3-4→3), serum NLR as a number (<9 → 0, >9 → 1), tumour type (mesothelioma/haematological 0; breast/gynaecological/renal_cell 1; lung/other 2). Score 0-7: 0-1 low, 2-4 moderate, 5-7 high. Equality at 1500 or 9 is not scored. Not a diagnosis or treatment order.

Campbell 2010 RDOS for patients unable to self-report dyspnea. Eight caller-assigned 0-2 integers (heart_rate, respiratory_rate, restlessness, paradoxical_breathing, accessory_muscle_use, grunting, nasal_flaring, look_of_fear). magent sums only (max 16); does not convert raw heart or respiratory rate or observe the patient. Campbell 2010 published the 0-16 instrument; magent does not apply later cutoff papers. Not a medical device and not an opioid or oxygen order.

Goetz 2004 modified Hoehn and Yahr stage (Table 1). Caller-assigned tokens 1.0, 1.5, 2.0, 2.5, 3.0, 4.0, or 5.0 with the published description. No stage 0. Not the original integer-only 1-5 scale, not UPDRS, not a diagnosis, and not an outcome measure. magent does not examine the patient. Not a medical device.

Thieblemont 2017 MALT-IPI (IELSG-19): age ≥70, Ann Arbor III or IV, LDH > ULN; 1 point each, max 3. Low 0, intermediate 1, high ≥2. Deterministic published score with citation; not a lymphoma diagnosis or treatment choice; original MALT-IPI, not Revised MALT-IPI (no MMS; age is ≥70 not >60), not Shipp IPI. magent does not stage lymphoma or assay LDH.

Mahoney 1965 Barthel Index: ten caller-assigned activity points (feeding, bathing, grooming, dressing, bowels, bladder, toilet, transfers, mobility, stairs) using that paper's 0/5, 0/5/10, or 0/5/10/15 values. magent sums only (max 100 in fives) and does not observe the patient. Not the Collin 0-20 Barthel and not a disability rating or placement decision.

Singer 2013 ATRIA stroke risk score (not Fang 2011 ATRIA bleed). Age x prior stroke Table 3: <65 0/8, 65-74 3/7, 75-84 5/7, >=85 6/9 without/with prior stroke. Plus 1 each: female, diabetes, heart failure, hypertension, proteinuria, eGFR<45 or ESRD. Max 15 (12 without prior stroke). 0-5 low, 6 moderate, 7-15 high. Not a stroke diagnosis or anticoagulation order. Not CHA2DS2-VASc. magent does not assay eGFR or urine.

CCS 2014 CHADS-65 algorithm for nonvalvular AF/AFL stroke-prevention discussion. Oral anticoagulant if age ≥65 or CHF, hypertension, diabetes, or prior stroke/TIA. Else aspirin if coronary, aortic, or peripheral arterial disease. Else none. Not CHADS2, not CHA2DS2-VASc, not HAS-BLED, and not an anticoagulation order. magent does not examine the patient.

mSOAR (Abdul-Rahim 2016 Stroke): SOAR plus NIHSS for early mortality after acute stroke. Age ≤65 0, 66-85 1, >85 2; infarct 0, hemorrhage 1; OCSP LACS/PACS 0, POCS 1, TACS 2; prestroke mRS 0-2 0, 3-4 1, 5 2; NIHSS 0-4 0, 5-10 1, ≥11 2. Max 9. Table 2 derivation percents for scores 0-1 through 7. Not a care-withdrawal decision. magent does not examine the patient or score NIHSS items.

Cox 1987 EPDS: 10 caller-assigned integers 0-3 (past 7 days). laugh, enjoyment, and anxious are reverse-scored in that paper; the caller assigns the published 0-3 (0 = least symptomatic pole after that reverse key). Total 0-30. This paper's threshold is 12/13 (at or above iff score ≥13). magent does not interview, apply later ≥10 community cuts, PHQ-9, QIDS, or MDI. Not a diagnosis.

Trubiano 2020 PEN-FAST for patients who already report a penicillin allergy. Three caller-assigned flags: allergy event 5 or fewer years ago (2), anaphylaxis/angioedema or potential SCAR as one criterion (2), treatment required (1). Max 5. Risk: 0 very_low, 1–2 low, 3 moderate, 4–5 high. low_risk_for_testing iff score < 3. Not an allergy diagnosis or delabeling order. magent does not take an allergy history.

Hlatky 1989 Duke Activity Status Index. Twelve caller-assigned yes/no items (self-care through strenuous sports); Yes adds the Table I weight, No adds 0. Light housework is 2.70. DASI is the sum (0-58.2). Estimated peak VO2 mL/kg/min = 0.43 x DASI + 9.6. magent does not observe the patient. Not a functional-capacity assignment or exercise-test replacement.

Gomez 2016 Step-by-Step for febrile infants 90 days and younger (derivation Mintegi 2014). High if ill-appearing, age 21 days or younger, leukocyturia, or PCT >=0.5 ng/mL; else intermediate if CRP >20 mg/L or ANC >10000/uL; else low. Returns risk, low_risk, high_risk, and intermediate_risk. magent does not examine the infant or assay UA, PCT, CRP, or ANC. Not Rochester, Boston, Philadelphia, or PECARN febrile. Not a medical device and not a discharge, admission, LP, or antibiotic order.

Motzer 1999 MSKCC: KPS <80, LDH >1.5×ULN, hemoglobin <LLN, corrected calcium >10 mg/dL, no prior nephrectomy; 1 point each, max 5. Favorable 0, intermediate 1–2, poor ≥3. Deterministic published score with citation; not an RCC diagnosis or treatment recommendation; not IMDC; not Motzer 2002/2004. magent does not assign KPS or assay LDH, hemoglobin, or calcium.